Dr. Maksym Kuchma leads the scientific direction of EvoPair, integrating immunology, molecular genetics, and reproductive genomics into a clinically and biologically validated framework for genetic matching between partners.
He holds a PhD in molecular immunology with a focus on vaccine-induced immunity and antiviral protection, complement
Dr. Maksym Kuchma leads the scientific direction of EvoPair, integrating immunology, molecular genetics, and reproductive genomics into a clinically and biologically validated framework for genetic matching between partners.
He holds a PhD in molecular immunology with a focus on vaccine-induced immunity and antiviral protection, complemented by medical qualifications in pediatrics, clinical immunology, and allergology. With more than 13 years of combined clinical and laboratory research experience, Dr. Kuchma has worked within leading European scientific centers, including the Czech Academy of Sciences and the International Institute of Molecular and Cell Biology in Warsaw.
His expertise covers immune-response modeling, rare disease variant interpretation, DNA and RNA sequencing workflows, host–pathogen interactions, and translational genomic analytics.
Dr. Kuchma is currently part of the scientific team at Cedars-Sinai Medical Center in Los Angeles, one of the nation’s premier biomedical research institutions. His work contributes to advancements in human tissue regeneration, molecular pathway engineering, and next-generation artificial tissue systems.
Within EvoPair, he ensures the scientific rigor, safety, and accuracy of the platform’s genomic-matching technology, guiding the development of responsible innovation in personalized reproductive planning and future-family genomics.
Anastasiia is the creator and strategic architect behind EvoPair, a cutting-edge reproductive technology platform focused on DNA-based co-parenting.
She defines the platform’s concept, product logic, and long-term technological direction. With a background in entrepreneurship since 2013 and active involvement in technology since 2017, she
Anastasiia is the creator and strategic architect behind EvoPair, a cutting-edge reproductive technology platform focused on DNA-based co-parenting.
She defines the platform’s concept, product logic, and long-term technological direction. With a background in entrepreneurship since 2013 and active involvement in technology since 2017, she operates at the intersection of product systems, secure data logic, behavioral algorithms, and regulated-environment workflows. Her experience includes designing end-to-end digital platforms, escrow-based systems, and compliance-aware user flows built around federal procedures, risk assessment, and high-trust interaction models.
By integrating genetic compatibility insights, she combines systems thinking, UX architecture, and cross-disciplinary product strategy, translating scientific models into scalable technological solutions. As the founder of EvoPair, she shapes the vision for intentional parenthood, sets the structural logic of the platform, drives key architectural decisions, and ensures system integrity from concept to deployment.
Independent development company operating since 2021. We design and build complex digital systems, including SaaS solutions, secure data platforms, and high-trust interaction models. Our work encompasses architecture, product logic, and end-to-end implementation, from early concept and system design to scalable infrastructure and cross-mo
Independent development company operating since 2021. We design and build complex digital systems, including SaaS solutions, secure data platforms, and high-trust interaction models. Our work encompasses architecture, product logic, and end-to-end implementation, from early concept and system design to scalable infrastructure and cross-module integration. The company operates across multiple domains — AI, cryptography, blockchain logic, compliance-driven workflows, and applied biotechnology — with a focus on technologies where data integrity and security are paramount. Notably, we are developing a reproductive technology platform that supports DNA-based co-parenting, such as our EvoPair solution, which emphasizes genetic compatibility for intentional parenthood. Business CHAIN develops its own products and supports founders whose projects require strong technical execution, reliability, and long-term scalability.
EvoPair
